Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer. [electronic resource]
Producer: 19960801Description: 2424-6 p. digitalISSN:- 0959-8049
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carboplatin -- administration & dosage
- Carcinoma, Small Cell -- drug therapy
- Carmustine -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Epirubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Letter
There are no comments on this title.
Log in to your account to post a comment.